elagolix   Click here for help

GtoPdb Ligand ID: 8362

Synonyms: compound 10b [PMID 19006286] | NBI-56418 | NBI56418 | Orilissa®
Approved drug PDB Ligand
elagolix is an approved drug (FDA (2018))
Compound class: Synthetic organic
Comment: Elagolix is a non-peptide gonadotrophin receptor (GnRHR) antagonist [1]. As of July 2018, it is the first and only FDA-approved oral GnRH antagonist available for the treatment of moderate to severe endometriosis pain.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 13
Topological polar surface area 102.56
Molecular weight 631.21
XLogP 7.35
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cccc(c1F)c1c(=O)n(CC(c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F
Isomeric SMILES COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F
InChI InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1
InChI Key HEAUOKZIVMZVQL-VWLOTQADSA-N
References
1. Chen C, Wu D, Guo Z, Xie Q, Reinhart GJ, Madan A, Wen J, Chen T, Huang CQ, Chen M et al.. (2008)
Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor.
J Med Chem, 51 (23): 7478-85. [PMID:19006286]
2. Lamb YN. (2018)
Elagolix: First Global Approval.
Drugs, 78 (14): 1501-1508. [PMID:30194661]